Trial Profile
The study of Immucyst for the prophylaxis of the superficial bladder cancer at a intermediate risk for the intravesical recurrence
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 24 Sep 2015
Price :
$35
*